Page 6

GrandRounds Kirkland Cancer Center Receives Recognition for High-Quality Cancer Care from Largest Oncology Society

JACKSON - Kirkland Cancer Center has been recognized by the QOPI® Certification Program (QCP™), an affiliate of the American Society of Clinical Oncology (ASCO®), as successfully completing a three-year certification program for outpatient hematologyoncology practices that meet nationally recognized standards for quality cancer care. QCP™ builds on ASCO’s Quality Oncology Practice Initiative (QOPI®). “We are thrilled to receive this certification from the QOPI® Certification Program, which reinforces our commitment to excellence for our patients at the Kirkland Cancer Center,” said Gina S. Myracle, Executive Director of the Alice and Carl Kirkland Cancer Center. In applying for certification, Kirkland Cancer Center participated in a voluntary comprehensive site assessment against clearly specified standards

that are consistent with national guidelines and was successful in meeting the standards and objectives of QCP™. “ASCO’s QOPI Certification demonstrates an oncology practice’s dedi-


To be notified when the next issue is posted online, please send your email address to




cation to providing high-quality care to patients with cancer,” said ASCO President Bruce E. Johnson, MD, FASCO. “The certification process is rigorous and by successfully completing it, providers put into practice their commitment to QOPI® analyzes individual prac-

tice data and compares these to more than 160 evidence-based and consensus quality measures. The information is then provided in reports to participating practices. Individual practices also are able to compare their performance to data from other practices across the country. Based on this feedback, doctors and practices can identify areas for improvement. To become QOPI® Certified, practices have to submit to an evaluation of their entire practice and documentation standards. The QCP™ staff and task force members then verify through an on-site survey that the evaluation and documents are correct and that the practices met core standards in areas of treatment, including: • Creating a safe environment— staffing, competencies, and general policy • Treatment planning, patient consent, and education • Ordering, preparing, dispensing, and administering chemotherapy • Monitoring after chemotherapy is administered, including adherence, toxicity, and complications • Treatment planning

Lending a Hand, continued from page 5 One of the surgeons at Tulane suggested he try Le Bonheur instead. He got the job, and felt fortunate about it. “People who are ‘crazy’ enough, or diligent or ambitious enough to pursue pediatric cardiac surgery – you study for 19 years after high school, and the surgical training is 12 years,” he said. “At the end of that there is no guarantee of a job. “The number of pediatric cardiac surgeons in the United States is roughly about 150. It’s a very, very highly specialized and highly competitive field. The year I was training there were about 30 of us who were doing some form of pediatric cardiac fellowship, and there were only three of us who got jobs.” He started at Le Bonheur as the junior surgeon along with two other surgeons, Dr. Chris Gilbert and Dr. Jeff Meyers. Within a year, Dr. Gilbert left for another job, and not long after that Dr. Meyers took a job in Boston. “This is a specialty where you need good mentorship during training and, even more important, after your training. So I was by myself and had to carry the cardiac program here at Le Bonheur for two or three years before I got some help. “It was trying times, I would say.” In 2012, Dr. Boston left Le Bonheur to go to Washington University in St. Louis. A big reason was that Le Bonheur’s heart program, in his mind, wasn’t at the level where it needed to be. “We did not have a heart transplant program,” he said, “and one of my big interests is in transplantation of children with congenital heart disease. Washington U. and St. Louis Children’s Hospital provided that opportunity. I didn’t leave Le Bonheur with any ill feelings. I really

wanted to build a transplant program.” In 2015, he got that chance. Le Bonheur upgraded its commitment and brought Dr. Boston back. “During the time I was gone, there was a change in plan,” he said, “and the direction was ‘OK, if we’re going to be a top-notch program, we need to provide all these services.’ They saw what the future of cardiac surgery was looking like.” While he was in St. Louis, Dr. Boston said, Le Bonheur sent him four to six transplant patients each year. But then the hospital demonstrated its commitment by hiring Dr. Jeffrey A. Towbin, who, Dr. Boston said, “is one of the big names in cardiomyopathy and transplantation in the country.” Dr. Towbin is now co-director of the Heart Institute at Le Bonheur. Upon Dr. Boston’s return, he said, “we knuckled down, built the infrastructure and obtained the resources that are required to start a heart transplant program.” “By October 2016 we did our first heart transplant,” Dr. Boston said. “By December 2016 we had performed two heart transplants and had put in two mechanical devices. And in 2017 we really exploded and did 12 transplants, probably some of the more complex heart transplants that we can do.” Donor hearts come primarily from remote sites within a 500-mile radius of Memphis, which encompasses a population of 92 million people. “The donor heart doesn’t last forever,” Dr. Boston said. “So within 20 years a baby will require another heart. I wouldn’t say transplantation is a cure. It provides a better quality of life for the child. Hopefully, with the development of advanced therapies, the donor heart may last longer.” westtnmedicalnews


February 2018 WTMN  

West TN Medical News February 2018

February 2018 WTMN  

West TN Medical News February 2018